Keyphrases
HIV Patients
100%
Highly Active Antiretroviral Therapy (HAART)
100%
Patient Outcomes
100%
Anal Squamous Cell Carcinoma
100%
Overall Survival
80%
Cancer-specific Survival
60%
Radiotherapy
40%
Chemoradiotherapy
40%
Anal Cancer
40%
Median Time
20%
Multivariate Analysis
20%
Viral Load
20%
HIV-related
20%
CD4 Count
20%
Treatment Regimen
20%
Local Recurrence
20%
Negative Impact
20%
Tumor Size
20%
Improved Survival
20%
Acute Toxicity
20%
Diarrhea
20%
Health Centers
20%
Hematotoxicity
20%
Early Diagnosis
20%
Mitomycin C
20%
Risk-adapted Therapy
20%
Cancer Care
20%
5-fluorouracil (5-FU)
20%
Locoregional Recurrence
20%
Treatment-related Morbidity
20%
Local Toxicity
20%
High Viral Load
20%
Local Relapse
20%
Early Risk
20%
St. Vincent
20%
Combined Chemoradiotherapy
20%
Radiotherapy Interruption
20%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Highly Active Antiretroviral Therapy
100%
Squamous Cell Carcinoma
100%
Overall Survival
66%
Cancer Specific Survival
50%
Chemoradiotherapy
50%
Radiation Therapy
50%
Recurrent Disease
33%
Anal Cancer
33%
Malignant Neoplasm
16%
Neoplasm
16%
Diarrhea
16%
Early Diagnosis
16%
Mitomycin
16%
Fluorouracil
16%
Acute Toxicity
16%
Multivariate Analysis
16%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Squamous Cell Carcinoma
100%
Overall Survival
66%
Cancer Specific Survival
50%
Chemoradiation Therapy
50%
Recurrent Disease
33%
Anus Cancer
33%
Malignant Neoplasm
16%
Neoplasm
16%
Diarrhea
16%
Fluorouracil
16%
Mitomycin
16%
Acute Toxicity
16%